Treatment Therapies in Pancreatic Carcinoma

Pancreatic cancer is the fourth leading cause of cancer deaths, being responsible for 7% of all cancer-related deaths in both men and women. Approximately 75% of all pancreatic carcinomas occur within the head or neck of the pancreas, 15-20% occurs in the body of the pancreas, and 5-10% occurs in the tail. Scientists are learning more about some of the changes in DNA that cause cells in the pancreas to become cancerous. Inherited changes in genes such as BRCA2, p16, and the genes responsible for hereditary non-polyposis colorectal cancer (HNPCC) can increase a person’s risk of developing pancreatic cancer.

  • Proton therapy
  • Radiation therapy
  • Chemotherapy
  • Immunotherapy
  • Ablation or embolization treatments

Related Conference of Treatment Therapies in Pancreatic Carcinoma

April 08-09, 2026

14th World Gastro Summit

London, UK
June 18-19, 2026

9th International Congress on Viral Hepatitis

Paris, France
August 03-04, 2026

21st Euro-Global Gastroenterology Conference

London, UK
September 29-30, 2026

7th Global Summit on Earth Science and Climate Change

Aix-en-Provence, France

Treatment Therapies in Pancreatic Carcinoma Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in